Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.1350
-0.0050 (-3.57%)
At close: Mar 31, 2026
Imugene Market Cap
Imugene has a market cap or net worth of 48.2 million as of March 31, 2026. Its market cap has decreased by -81.01% in one year.
Market Cap
48.20M
Enterprise Value
39.04M
Revenue
3.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 48.20M, an increase of 553.17%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 49.98M | -56.82% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 82.09M |
| LTR Pharma | 72.71M |
| Cynata Therapeutics | 71.24M |
| Radiopharm Theranostics | 70.88M |
| Immutep | 70.74M |
| Prescient Therapeutics | 58.88M |
| Neurizon Therapeutics | 56.65M |
| Proteomics International Laboratories | 47.90M |